Colour photographs for screening in neovascular age-related macular degeneration: Are they necessary

Eye

Volumn 25, Issue 7, 2011, Pages 918-921

  Hibbs, S P ^a   Smith, A ^b   Chow, L P ^c   Downes, S M ^c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b ROYAL BERKSHIRE HOSPITAL   (United Kingdom)

^c OXFORD EYE HOSPITAL   (United Kingdom)

Author keywords

age related macular degeneration; AMD; choroidal neovascularisation; exudative AMD, OCT; retinal imaging

Indexed keywords

RANIBIZUMAB;

ARTICLE; CLINICAL DECISION MAKING; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ACTIVITY; EYE PHOTOGRAPHY; HUMAN; INFRARED PHOTOGRAPHY; MAJOR CLINICAL STUDY; OPHTHALMOSCOPY; OPTICAL COHERENCE TOMOGRAPHY; RETINA EDEMA; RETINA HEMORRHAGE; RETINA IMAGE; RETINA MACULA AGE RELATED DEGENERATION; RETINA NEOVASCULARIZATION; RETREATMENT; SENSITIVITY AND SPECIFICITY;

EID: 79960449691     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2011.90     Document Type: Article

References (7)

1. Pascolini D, Mariotti SP, Pokharel GP, Pararajasegaram R, Etyaale D, Négrel AD et al. 2002 Global update of available data on visual impairment: a compilation of populationbased prevalence studies. Ophthalmic Epidemiol 2004; 11: 67-115. (Pubitemid 38530465)
2. Brown DM, Kaiser PK, Michels M, Soubrane G, Heier JS, Kim RY et al. ANCHOR Study Group. Ranibizumab vs verteporfin for neovascular age-related macular degeneration. N Engl J Med 2006; 355: 1432-1444. (Pubitemid 44511558)
3. Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY et al. MARINA Study Group, ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006; 355(14): 1419-1431. (Pubitemid 44511557)
4. Fung AE, Lalwani GA, Rosenfeld PJ, Dubovy SR, Michels S, Feuer WJ et al. An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration. Am J Ophthalmol 2007; 143: 566-583.
5. Hogg R, Curry E, Muldrew A, Winder J, Stevenson M, McClure M et al. Identification of lesion components that influence visual function in age related macular degeneration. Br J Ophthalmol 2003; 87(5): 609-614. (Pubitemid 36535336)
6. Coscas F, Coscas G, Souied E, Tick S, Soubrane G. Optical coherence tomography identification of occult choroidal neovascularization in age-related macular degeneration. Am J Ophthalmol 2007; 144(4): 592-599.
7. Maberley DA, Isbister C, Mackenzie P, Aralar A. An evaluation of photographic screening for neovascular agerelated macular degeneration. Eye (Lond) 2005; 19(6): 611-616. (Pubitemid 40895471)